MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Clinical trials for MALIGNANT PLEURAL MESOTHELIOMA (MPM) explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA (MPM) trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMA (MPM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer pill shows promise in early trial for tough tumors
Disease control Recruiting nowThis early-stage study tests an experimental drug called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug works by boosting the immune system to fight tumors. The main goals are to check safety and find the right dose, with a later …
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Scientists map immune cells in rare cancer to boost immunotherapy
Knowledge-focused Recruiting nowThis study looks at the immune system inside malignant pleural mesothelioma tumors. Researchers want to understand why immunotherapy doesn't work for many patients. They will analyze tumor samples from 300 adults to find patterns that could help doctors choose better treatments i…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 09:35 UTC